| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |